Search research articles
Contact Us
Filters
Showing results (1-10 of 184) with videos related to
Page
of 19
Sort By:
F1000 Medicine Reports
|
October 16, 2010
Antiproliferative effects of somatostatin analogs in endocrine tumours
Maria Chiara Zatelli
Pituitary
|
February 7, 2018
Pathogenesis of non-functioning pituitary adenomas
Maria Chiara Zatelli
Pituitary
|
October 28, 2025
Is the somatostatin receptor type 5 expression important in resistant prolactinomas?
Laura Chinezu, Maria Chiara Zatelli
Current Opinion in Investigational Drugs (London, England : 2000)
|
September 25, 2009
The significance of new somatostatin analogs as therapeutic agents
Maria Chiara Zatelli, Ettore degli Uberti
Seminars in Reproductive Medicine
|
October 28, 2008
MicroRNAs and possible role in pituitary adenoma
Maria Chiara Zatelli, Ettore C degli Uberti
Endocrine
|
March 4, 2021
Neoadjuvant PRRT for advanced pNEN: an unusual highlander
Isabella Zanata, Maria Rosaria Ambrosio, Maria Chiara Zatelli
Best Practice & Research. Clinical Endocrinology & Metabolism
|
December 8, 2016
Strategies to use microRNAs as therapeutic targets
Erica Gentilin, Ettore Degli Uberti, Maria Chiara Zatelli
Endocrine
|
January 17, 2022
"The past is a different country, they do things differently there": using the SEER data-base to assess prognosis in neuroendocrine tumours
Krystallenia I Alexandraki, Maria Chiara Zatelli, Ashley B Grossman
Journal of Endocrinological Investigation
|
May 7, 2025
The mystery of Mont'e Prama: sculptures, acromegaly, and nuragic society
Valentino Marino Picciola, Maria Rosaria Ambrosio, Maria Chiara Zatelli
Journal of Endocrinological Investigation
|
August 12, 2025
Art, diet and thyroid disease: interpreting the goiter motif in the trivulzio tapestries
Valentino Marino Picciola, Maria Chiara Zatelli, Luigi Massimino Sena
Page
of 19
Search research articles
Search
Showing results (1-10 of 184) with videos related to
Sort By:
Page
of 19
F1000 Medicine Reports
|
October 16, 2010
Antiproliferative effects of somatostatin analogs in endocrine tumours
Maria Chiara Zatelli
Pituitary
|
February 7, 2018
Pathogenesis of non-functioning pituitary adenomas
Maria Chiara Zatelli
Pituitary
|
October 28, 2025
Is the somatostatin receptor type 5 expression important in resistant prolactinomas?
Laura Chinezu, Maria Chiara Zatelli
Current Opinion in Investigational Drugs (London, England : 2000)
|
September 25, 2009
The significance of new somatostatin analogs as therapeutic agents
Maria Chiara Zatelli, Ettore degli Uberti
Seminars in Reproductive Medicine
|
October 28, 2008
MicroRNAs and possible role in pituitary adenoma
Maria Chiara Zatelli, Ettore C degli Uberti
Endocrine
|
March 4, 2021
Neoadjuvant PRRT for advanced pNEN: an unusual highlander
Isabella Zanata, Maria Rosaria Ambrosio, Maria Chiara Zatelli
Best Practice & Research. Clinical Endocrinology & Metabolism
|
December 8, 2016
Strategies to use microRNAs as therapeutic targets
Erica Gentilin, Ettore Degli Uberti, Maria Chiara Zatelli
Endocrine
|
January 17, 2022
"The past is a different country, they do things differently there": using the SEER data-base to assess prognosis in neuroendocrine tumours
Krystallenia I Alexandraki, Maria Chiara Zatelli, Ashley B Grossman
Journal of Endocrinological Investigation
|
May 7, 2025
The mystery of Mont'e Prama: sculptures, acromegaly, and nuragic society
Valentino Marino Picciola, Maria Rosaria Ambrosio, Maria Chiara Zatelli
Journal of Endocrinological Investigation
|
August 12, 2025
Art, diet and thyroid disease: interpreting the goiter motif in the trivulzio tapestries
Valentino Marino Picciola, Maria Chiara Zatelli, Luigi Massimino Sena
Page
of 19